No announcement yet.

FDA panel supports approval of powerful MS drug Lemtrada

  • Filter
  • Time
  • Show
Clear All
new posts

  • FDA panel supports approval of powerful MS drug Lemtrada

    Lemtrada (alemtuzumab) is a powerful chemotherapy drug that has the potential to put the brakes on MS for a good bit. It does have a few big cons, but for those failing other treatments, it could be a (quality of) life saver. - Dave

    UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada

    By Deborah Zabarenko

    Nov 13 (Reuters) - A federal advisory panel recommended approval of Sanofi SA's experimental multiple sclerosis drug Lemtrada on Wednesday, but said the drug should be reserved for patients who have failed other therapies.

    In a surprise decision, an advisory panel to the Food and Drug Administration voted 14 to 0 that the drug should be approved despite its potential to cause cancer and other serious conditions.

    "Do I want to take this drug? No way!" said Dr. Nathan Fountain of the University of Virginia School of Medicine and the panel's chairperson. But for some patients, he said, it could be appropriate. "I wouldn't want to deny those people," he said.
    Dave Bexfield